Latest Nature Medicine Stories
For the first time, scientists at the Toronto General Hospital Research Institute have shown that an experimental bariatric surgery can lower blood sugar levels in rats with type 1 diabetes.
The Stem Cells and Cancer Research Group headed by Dr Héctor G. Palmer at the Vall d'Hebrón Institute of Oncology (VHIO) has identified the molecular mechanisms that determine patients' response to certain drugs used in clinical trials for colon cancer treatment.
Why diabetics suffer from increased pain and temperature sensitivity is a step closer to being understood and effectively treated.
A new link between obesity and type 2 diabetes found in mice could open the door to exploring new potential drug treatments for diabetes.
A Penn research team, led by Mitchell Lazar, MD, PhD, director of the Institute for Diabetes, Obesity, and Metabolism at the Perelman School of Medicine, University of Pennsylvania, reports in Nature Medicine that mice in which an enzyme called histone deacetylase 3 (HDAC3) was deleted had massively fatty livers, but lower blood sugar, and were thus protected from glucose intolerance and insulin resistance, the hallmark of diabetes.
When poet Walt Whitman wrote that we "contain multitudes," he was speaking metaphorically, but he was correct in the literal sense.
UCLA researchers pinpointed a new mechanism that potently activates T-cells, the group of white blood cells that play a major role in fighting infections.
Nature Medicine is a peer-reviewed academic journal established in 1995 and published monthly by the Nature Publishing Group, a division of Macmillan Publishers Ltd. As with other Nature journals, this periodical has no external Editorial Board, with editorial decisions being made by an in-house team. Nature Medicine publishes research articles, reviews, news and commentary pieces. Topics include cancer, cardiovascular disease, gene therapy, immunology, vaccines, and neuroscience. Research...
- An armed gangster.